✦ LIBER ✦

Safety Analysis of FOLFOX4 Treatment in Colorectal Cancer Patients: A Comparison Between Two Asian Studies and Four Western Studies

✍ Scribed by Kenichi Sugihara; Atsushi Ohtsu; Yasuhiro Shimada; Nobuyuki Mizunuma; Po-Huang Lee; Aimery de Gramont; Richard M. Goldberg; Mace L. Rothenberg; Thierry André; Silvano Brienza; Katsushige Gomi

Book ID: 116365641
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 574 KB
Volume: 11
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of FOLFOX4 in th

Safety and tolerability of FOLFOX4 in the adjuvant treatment of colon cancer in Asian patients: The MASCOT study

✍ Po-Huang LEE; Young-Suk PARK; Jia-Fu JI; Yiu-Tung FU; Vorachai RATANATHARATHORN 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

A combination of gefitinib and FOLFOX-4

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

✍ Cascinu, S; Berardi, R; Salvagni, S; Beretta, G D; Catalano, V; Pucci, F; Sobrer 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Consistent efficacy and safety of gemcit

Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: A retrospective comparison of East Asian and global studies

✍ Xu, Binghe; Zhang, Xiao Qing; Chi, Hai Dong; Liu, Zhixin; Quinlivan, Mitchell; O 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

698 PUBLICATION Efficacy and safety find

698 PUBLICATION Efficacy and safety findings from a phase II study of capecitabine (X) as first-line therapy in Japanese patients (pts) with metastatic colorectal cancer (MCRC): comparison with published Western data

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A Phase 2b, Double-Blind, Randomized Stu

A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT Trial

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB